BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

676 related articles for article (PubMed ID: 23216466)

  • 1. Hearing preservation in patients with vestibular schwannoma treated with Gamma Knife surgery.
    Baschnagel AM; Chen PY; Bojrab D; Pieper D; Kartush J; Didyuk O; Naumann IC; Maitz A; Grills IS
    J Neurosurg; 2013 Mar; 118(3):571-8. PubMed ID: 23216466
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Factors associated with hearing preservation after Gamma Knife surgery for vestibular schwannomas in patients who retain serviceable hearing.
    Hasegawa T; Kida Y; Kato T; Iizuka H; Yamamoto T
    J Neurosurg; 2011 Dec; 115(6):1078-86. PubMed ID: 21961962
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gamma knife radiosurgery for vestibular schwannoma: early hearing outcomes and evaluation of the cochlear dose.
    Lasak JM; Klish D; Kryzer TC; Hearn C; Gorecki JP; Rine GP
    Otol Neurotol; 2008 Dec; 29(8):1179-86. PubMed ID: 18931646
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Predictors of hearing preservation after stereotactic radiosurgery for acoustic neuroma.
    Kano H; Kondziolka D; Khan A; Flickinger JC; Lunsford LD
    J Neurosurg; 2009 Oct; 111(4):863-73. PubMed ID: 19284227
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gamma knife radiosurgery for vestibular schwannomas: results of hearing preservation in relation to the cochlear radiation dose.
    Timmer FC; Hanssens PE; van Haren AE; Mulder JJ; Cremers CW; Beynon AJ; van Overbeeke JJ; Graamans K
    Laryngoscope; 2009 Jun; 119(6):1076-81. PubMed ID: 19399836
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term hearing outcomes following stereotactic radiosurgery for vestibular schwannoma: patterns of hearing loss and variables influencing audiometric decline.
    Carlson ML; Jacob JT; Pollock BE; Neff BA; Tombers NM; Driscoll CL; Link MJ
    J Neurosurg; 2013 Mar; 118(3):579-87. PubMed ID: 23101446
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term follow-up studies of Gamma Knife surgery for patients with neurofibromatosis Type 2.
    Sun S; Liu A
    J Neurosurg; 2014 Dec; 121 Suppl():143-9. PubMed ID: 25434947
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Longitudinal analysis of hearing before and after radiosurgery for vestibular schwannoma.
    Yomo S; Carron R; Thomassin JM; Roche PH; Régis J
    J Neurosurg; 2012 Nov; 117(5):877-85. PubMed ID: 22937934
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Stereotactic radiosurgery for vestibular schwannomas: average 10-year follow-up results focusing on long-term hearing preservation.
    Watanabe S; Yamamoto M; Kawabe T; Koiso T; Yamamoto T; Matsumura A; Kasuya H
    J Neurosurg; 2016 Dec; 125(Suppl 1):64-72. PubMed ID: 27903183
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A comprehensive analysis of hearing preservation after radiosurgery for vestibular schwannoma.
    Yang I; Sughrue ME; Han SJ; Aranda D; Pitts LH; Cheung SW; Parsa AT
    J Neurosurg; 2010 Apr; 112(4):851-9. PubMed ID: 19747043
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Irradiation of cochlear structures during vestibular schwannoma radiosurgery and associated hearing outcome.
    Massager N; Nissim O; Delbrouck C; Delpierre I; Devriendt D; Desmedt F; Wikler D; Brotchi J; Levivier M
    J Neurosurg; 2007 Oct; 107(4):733-9. PubMed ID: 17937216
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Significance of cochlear dose in the radiosurgical treatment of vestibular schwannoma: controversies and unanswered questions.
    Jacob JT; Carlson ML; Schiefer TK; Pollock BE; Driscoll CL; Link MJ
    Neurosurgery; 2014 May; 74(5):466-74; discussion 474. PubMed ID: 24476904
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Predictors of hearing loss after gamma knife radiosurgery for vestibular schwannomas: age, cochlear dose, and tumor coverage.
    Brown M; Ruckenstein M; Bigelow D; Judy K; Wilson V; Alonso-Basanta M; Lee JY
    Neurosurgery; 2011 Sep; 69(3):605-13; discussion 613-4. PubMed ID: 21471832
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of hearing function after Gamma Knife surgery of vestibular schwannomas.
    Franzin A; Spatola G; Serra C; Picozzi P; Medone M; Milani D; Castellazzi P; Mortini P
    Neurosurg Focus; 2009 Dec; 27(6):E3. PubMed ID: 19951056
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Functional Preservation After Planned Partial Resection Followed by Gamma Knife Radiosurgery for Large Vestibular Schwannomas.
    Iwai Y; Ishibashi K; Watanabe Y; Uemura G; Yamanaka K
    World Neurosurg; 2015 Aug; 84(2):292-300. PubMed ID: 25790872
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term tumor control and cranial nerve outcomes following γ knife surgery for larger-volume vestibular schwannomas.
    Milligan BD; Pollock BE; Foote RL; Link MJ
    J Neurosurg; 2012 Mar; 116(3):598-604. PubMed ID: 22175724
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Preservation of hearing in vestibular schwannomas treated by radiosurgery using Leksell Gamma Knife: preliminary report of a prospective Belgian clinical study.
    Delbrouck C; Hassid S; Massager N; Choufani G; David P; Devriendt D; Levivier M
    Acta Otorhinolaryngol Belg; 2003; 57(3):197-204. PubMed ID: 14571654
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fractionated stereotactic radiotherapy of vestibular schwannomas accelerates hearing loss.
    Rasmussen R; Claesson M; Stangerup SE; Roed H; Christensen IJ; Cayé-Thomasen P; Juhler M
    Int J Radiat Oncol Biol Phys; 2012 Aug; 83(5):e607-11. PubMed ID: 22560549
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gamma Knife radiosurgery for vestibular schwannoma: clinical results at long-term follow-up in a series of 379 patients.
    Boari N; Bailo M; Gagliardi F; Franzin A; Gemma M; del Vecchio A; Bolognesi A; Picozzi P; Mortini P
    J Neurosurg; 2014 Dec; 121 Suppl():123-42. PubMed ID: 25434946
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Progression of hearing loss after LINAC-based stereotactic radiotherapy for vestibular schwannoma is associated with cochlear dose, not with pre-treatment hearing level.
    van Linge A; van Os R; Hoekstra N; Heijmen B; Stienstra L; Dallenga A; Wolbers J; Mendez Romero A
    Radiat Oncol; 2018 Dec; 13(1):253. PubMed ID: 30583739
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 34.